<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2014-9-118-125</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-644</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Практика</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Practice</subject></subj-group></article-categories><title-group><article-title>Место доксициклина в современной клинической практике</article-title><trans-title-group xml:lang="en"><trans-title>Use of doxycycline in modern clinical practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>R. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голуб</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golub</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Смоленская государственная медицинская академия Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Smolensk State Medical Academy, Russia's Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2014</year></pub-date><volume>0</volume><issue>9</issue><fpage>118</fpage><lpage>125</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козлов Р.С., Голуб А.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Козлов Р.С., Голуб А.В.</copyright-holder><copyright-holder xml:lang="en">Kozlov R.S., Golub A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/644">https://www.med-sovet.pro/jour/article/view/644</self-uri><abstract><p>Данный обзор продолжает серию публикаций о хорошо известных «классических» антимикробных препаратах, использование которых в клинической практике приобретает новый смысл в свете стремления ограничить глобальный рост резистентности возбудителей инфекционных заболеваний к антибиотикам. Так, например, доксициклин показан при не теряющих значимости инфекциях, передаваемых половым путем, воспалительных заболеваниях органов малого таза, инфекциях нижних дыхательных путей, некоторых инфекциях кожи, периодонтите. Препарат остается по-прежнему актуальным и для решения сложных вопросов профилактики и терапии ряда зоонозов (в т. ч. особо опасных инфекций) и трансмиссивных заболеваний, что делает его стратегически важным продуктом для здравоохранения.</p></abstract><trans-abstract xml:lang="en"><p>The review continues the publication series devoted to well-known "classical" antimicrobial drugs the application of which in clinical practice takes on a new meaning in light of the striving to limit the globally increasing resistance of infectious diseases to antibiotics. For example, doxycycline is indicated for still relevant sexually transmitted infections, pelvic inflammatory diseases, lower respiratory tract infections, some skin infections and periodontitis. Antibiotic drug remains crucial in addressing the complex issues of prevention and treatment of a number of zoonotic diseases (including special danger infections) and vector-borne diseases, making it a strategic product for healthcare.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>доксициклин</kwd><kwd>воспалительные заболевания органов малого таза</kwd><kwd>хламидиоз</kwd><kwd>акне</kwd><kwd>угревая сыпь</kwd><kwd>розацеа</kwd><kwd>периодонтит</kwd><kwd>зооноз</kwd><kwd>клещевой боррелиоз</kwd><kwd>риккетсиоз</kwd><kwd>чума</kwd><kwd>сибирская язва</kwd><kwd>малярия</kwd><kwd>doxycycline</kwd><kwd>pelvic inflammatory diseases</kwd><kwd>chlamydiosis</kwd><kwd>acne</kwd><kwd>blackheads</kwd><kwd>rosacea</kwd><kwd>periodontitis</kwd><kwd>zoonosis</kwd><kwd>tick-borne borreliosis</kwd><kwd>rickettsiosis</kwd><kwd>plague</kwd><kwd>anthrax</kwd><kwd>malaria</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhanel GG, Homenuik K, Nichol K et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs, 2004, 64: 63-88.</mixed-citation><mixed-citation xml:lang="en">Zhanel GG, Homenuik K, Nichol K et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs, 2004, 64: 63-88.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline and doxycycline. Arch Dermatol, 1997, 133: 1224-30.</mixed-citation><mixed-citation xml:lang="en">Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline and doxycycline. Arch Dermatol, 1997, 133: 1224-30.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther, 2005, 27: 1329-42.</mixed-citation><mixed-citation xml:lang="en">Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther, 2005, 27: 1329-42.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR, 2010, 59: 110 p.</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR, 2010, 59: 110 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Naber KG, Bishop MC, Bjerklund-Johansen TE et al. Рекомендации европейской урологической ассоциации по ведению больных с инфекциями почек, мочевыводящих путей и инфекциями мужских половых органов. Современные клинические рекомендации по антимикробной терапии. Вып. 2. Смоленск: МАКМАХ; 2007. С. 352-565.</mixed-citation><mixed-citation xml:lang="en">Naber KG, Bishop MC, Bjerklund-Johansen TE et al. Рекомендации европейской урологической ассоциации по ведению больных с инфекциями почек, мочевыводящих путей и инфекциями мужских половых органов. Современные клинические рекомендации по антимикробной терапии. Вып. 2. Смоленск: МАКМАХ; 2007. С. 352-565.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Никонов А.П., Асцатурова О.Р Инфекции в акушерстве и гинекологии. Практическое руководство по диагностике и антимикробной химиотерапии. М.: Объединенная редакция «Боргес»; 2003.</mixed-citation><mixed-citation xml:lang="en">Никонов А.П., Асцатурова О.Р Инфекции в акушерстве и гинекологии. Практическое руководство по диагностике и антимикробной химиотерапии. М.: Объединенная редакция «Боргес»; 2003.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Horner P. Chlamydia (uncomplicated, genital). Clin Evid, 2010, 2010: 1607.</mixed-citation><mixed-citation xml:lang="en">Horner P. Chlamydia (uncomplicated, genital). Clin Evid, 2010, 2010: 1607.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Transm Infect, 2006, 82: 340-3.</mixed-citation><mixed-citation xml:lang="en">Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Transm Infect, 2006, 82: 340-3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tobin JM, Harindra V, Mani R. Which treatment for genital tract Chlamydia trachomatis infection? Int J STD AIDS, 2004, 15: 737-9.</mixed-citation><mixed-citation xml:lang="en">Tobin JM, Harindra V, Mani R. Which treatment for genital tract Chlamydia trachomatis infection? Int J STD AIDS, 2004, 15: 737-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
